Various aspects of breast cancer are associated with Zn influx transporters including breast cancer risk correlation with the ZIP6, ZIP7, and ZIP10 expression level; association of cancer cell invasion and metastasis with the ZIP6 expression; the estrogen receptor expression and disease aggressiveness and metastasis association with the ZIP6 expression; association of the ZIP-7 with high-risk disease and poor prognosis are reviewed by To et al., 2020 [70]. Here, SLC39A6 is linked to breast carcinoma.